Denali Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Denali Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,500	Closed	-$27.3K	–	555
2023 Q2	$27.3K	Hold	10,500	–	–	0.01%	322
2023 Q1	$38.6K	Hold	10,500	–	–	0.02%	240
2022 Q4	$18.6K	Hold	10,500	–	–	0.01%	306
2022 Q3	$42K	Buy	+10,500	New	+$64.6K	0.02%	231

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

Denali Advisors's DMTK Position: Q3 2023 in Review

Denali Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2023, closing a stake of 10,500 shares — an estimated $27.3K sold.

Denali Advisors first reported a position in DMTK in Q3 2022 and held it in 4 quarters. The position peaked at $42K in Q3 2022. 78 funds tracked by Wall St. Rank hold DMTK as of Q3 2023.

Denali Advisors reported no remaining DermTech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Denali Advisors sold 10,500 DermTech, Inc. Common Stock shares in Q3 2023, an estimated $27.3K.
Denali Advisors first reported a position in DermTech, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Denali Advisors's DermTech, Inc. Common Stock position peaked at $42K in Q3 2022.
78 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.